Dr. Sanford Chen, MD

Dr. Chen practices at Elite Surgery Center of Orange County Inc in Santa Ana, California.

Dr. Chen's NPI, 1427051994, was assigned on May 27, 2005. Dr. Chen graduated from University Of Michigan Medical School in 1987. Dr. Chen holds California license G077086.

Dr. Chen's primary practice is Elite Surgery Center of Orange County Inc, at 999 N Tustin Ave, Santa Ana, CA 92705 in Orange County. The practice phone is (949) 566-8688.

Dr. Chen's primary practice is Elite Surgery Center of Orange County Inc in Santa Ana, California. Dmand AI also links Dr. Chen to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chen's licenses on file in 3 states: California, Massachusetts and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Chen treats.

CMS data shows 192,219 Medicare services from Dr. Chen across 22 procedure codes in 2024, for 890 Medicare patients. Medicare paid $3,052,704 for them. Every service was in an office.

CMS counts 890 Medicare patients who saw Dr. Chen in 2024. The largest group is 75 to 84, with 360 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 73, with 55% women.

In 2024, Dr. Chen wrote 329 Medicare Part D claims for 100 patients. 41% of them were for generic drugs. CMS names the drug for 255 of them, across 11 drugs with 11 or more claims each, at $25,157 in total drug cost. In 2023, CMS named 344 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of cataract surgery by Dr. Chen, more than 39% of the clinicians it reports for that procedure.

Dmand AI links 117 papers to Dr. Chen, published from 2006 to 2022. 2020 was the busiest year, with 13. The most frequent topics are Visual Acuity, Tomography, Optical Coherence and Fluorescein Angiography. Dr. Chen has published most often in Retina. Dr. Chen's most frequent co-authors are John M. Maggiano, MD, Timothy T. You, MD and Rajiv Ramesh Rathod, MD.

Dmand AI links Dr. Chen to 8 clinical trials, 3 of them phase 3 studies. Conditions studied include Macular Degeneration, Retinal Vein Occlusion and Choroidal Neovascularization. The Emmes Company, LLC sponsors the most, 2. Open Payments lists research payments to Dr. Chen that name 1 trial.

CMS Open Payments shows 892 general payments to Dr. Chen from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $58,578. It also lists 11 research payments totaling $6,893 from 2019 to 2020, naming 1 clinical trial.

Dmand AI lists 8 awards for Dr. Chen, most recently Top Doctors:LA Area in 2013.

Dr. Chen graduated from University Of Michigan Medical School in 1987. Dr. Chen is a member of AAO, ACS, ASRS and CMA.

Dr. Chen is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.